DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar OpusPGladiator (78.64) Submitted: 9/25/2007 12:54:21 PM : Outperform Start Price: $5.38 DRRX Score: -74.26

Don't miss out on this potential Windfall!!! Give it a bit of time to make some great gains!!!

Featured Broker Partners


Advertisement